Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1979 1
1982 1
1984 1
1986 1
1987 2
1988 2
1990 3
1991 1
1992 1
1993 1
1994 1
1995 5
1996 4
1997 5
1998 3
1999 5
2001 2
2003 3
2004 4
2005 2
2007 3
2009 8
2010 3
2011 8
2012 4
2013 12
2014 5
2015 10
2016 6
2017 6
2018 5
2019 8
2020 12
2021 4
2022 8
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial.
Yousuf AJ, Mohammed S, Carr L, Yavari Ramsheh M, Micieli C, Mistry V, Haldar K, Wright A, Novotny P, Parker S, Glover S, Finch J, Quann N, Brookes CL, Hobson R, Ibrahim W, Russell RJ, John C, Grimbaldeston MA, Choy DF, Cheung D, Steiner M, Greening NJ, Brightling CE. Yousuf AJ, et al. Among authors: brookes cl. Lancet Respir Med. 2022 May;10(5):469-477. doi: 10.1016/S2213-2600(21)00556-7. Epub 2022 Mar 24. Lancet Respir Med. 2022. PMID: 35339234 Clinical Trial.
Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trial.
Morriss R, Briley PM, Webster L, Abdelghani M, Barber S, Bates P, Brookes C, Hall B, Ingram L, Kurkar M, Lankappa S, Liddle PF, McAllister-Williams RH, O'Neil-Kerr A, Pszczolkowski S, Suazo Di Paola A, Walters Y, Auer DP. Morriss R, et al. Among authors: brookes c. Nat Med. 2024 Feb;30(2):403-413. doi: 10.1038/s41591-023-02764-z. Epub 2024 Jan 16. Nat Med. 2024. PMID: 38228914 Free PMC article. Clinical Trial.
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.
Fennell DA, King A, Mohammed S, Greystoke A, Anthony S, Poile C, Nusrat N, Scotland M, Bhundia V, Branson A, Brookes C, Darlison L, Dawson AG, Gaba A, Hutka M, Morgan B, Bajaj A, Richards C, Wells-Jordan P, Thomas A; MiST2 study group. Fennell DA, et al. Among authors: brookes c. Lancet Oncol. 2022 Mar;23(3):374-381. doi: 10.1016/S1470-2045(22)00062-6. Epub 2022 Feb 11. Lancet Oncol. 2022. PMID: 35157829 Clinical Trial.
Pathway-based subnetworks enable cross-disease biomarker discovery.
Haider S, Yao CQ, Sabine VS, Grzadkowski M, Stimper V, Starmans MHW, Wang J, Nguyen F, Moon NC, Lin X, Drake C, Crozier CA, Brookes CL, van de Velde CJH, Hasenburg A, Kieback DG, Markopoulos CJ, Dirix LY, Seynaeve C, Rea DW, Kasprzyk A, Lambin P, Lio' P, Bartlett JMS, Boutros PC. Haider S, et al. Among authors: brookes cl. Nat Commun. 2018 Nov 12;9(1):4746. doi: 10.1038/s41467-018-07021-3. Nat Commun. 2018. PMID: 30420699 Free PMC article.
Classification of cell signalling in tissue development.
Platt CC, Nicholls C, Brookes C, Wood I. Platt CC, et al. Among authors: brookes c. Cell Commun Adhes. 2011 Feb;18(1-2):9-17. doi: 10.3109/15419061.2011.586755. Epub 2011 Jun 8. Cell Commun Adhes. 2011. PMID: 21651343 Review.
139 results